血管内皮生长因子受体1(VEGFR1)重组蛋白

Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)

Flt1; Fms-Related Tyrosine Kinase 1; Vascular Permeability Factor Receptor; Fms-like tyrosine kinase 1; Tyrosine-protein kinase receptor FLT

  • 血管内皮生长因子受体1(VEGFR1)重组蛋白 产品包装(模拟)
  • 血管内皮生长因子受体1(VEGFR1)重组蛋白 产品包装(模拟)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

PBS或其它。

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Mus musculus (Mouse,小鼠) 应用(仅供研究使用,不用于临床诊断!)
RPB818Mu02 血管内皮生长因子受体1(VEGFR1)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB818Mu01 血管内皮生长因子受体1(VEGFR1)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB818Mu01 血管内皮生长因子受体1(VEGFR1)多克隆抗体 WB; IHC; ICC; IP.
PAB818Mu02 血管内皮生长因子受体1(VEGFR1)多克隆抗体 WB; IHC; ICC; IP.
LAB818Mu71 血管内皮生长因子受体1(VEGFR1)多克隆抗体(生物素标记) WB; IHC; ICC.
SEB818Mu 血管内皮生长因子受体1(VEGFR1)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB818Mu 血管内皮生长因子受体1(VEGFR1)检测试剂盒(化学发光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.

参考文献

杂志 参考文献
Clinical cardiology Growth Differentiation Factor 15 and Coronary Collateral Formation [PubMed: 20014173]
Microvascular Research Mutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle [PubMed: 20937289]
Science Alert Antiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats [Scialert: Source]
Acta Biomater Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study [PubMed: 26689470]
Naunyn Schmiedebergs Arch Pharmacol The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis [PubMed: 26269412]
Acta Biomaterialia Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study [Pubmed:26689470]
留言咨询